Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688687.SS

SELLREMOVE

Beijing Kawin Technology Share-Holding Co., Ltd. · Healthcare · China · $431M · Avg Vol: $6M/d

24
StockRank
Q
54
V
31
M
30
P/E (TTM)
237.1x
ROE
1.1%
D/E
0.3x
Dividend %
1.5%
AI CONVICTION THESIS

Beijing Kawin is a small biotech firm that lacks internal manufacturing scale, leaving it highly vulnerable to rising manufacturing costs from dominant CDMOs.

COMPANY DESCRIPTION

Beijing Kawin Technology Share-Holding Co., Ltd. is a biopharmaceutical company specializing in the prevention and treatment of viral infections, with a focus on chronic hepatitis B and C. The company's competitive moat is anchored by its proprietary recombinant human interferon products and a robust pipeline of innovative biologics. It holds a leading position in China's antiviral therapeutic market.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue171M209M182M195M4.4%
EPS0.070.100.130.03-28.4%
Shares171M171M171M171M+0.0%
Debt2M8M37M75M218.4%
Equity248M259M272M252M0.6%
Op CF20M19M15M16M-6.3%
Inv CF-73M-9M-26M-47M
Fin CF-11M1M12M16M
Loading...
PRICE (1M)-16.0%
2.362.532.702.873.04Apr 30May 26Jun 15
SMA 50SMA 200
Close
$2.45
RSI (14)
38.4
52W High
$5.85
From 52W High
0.4%

SCORE BREAKDOWN

Quality
54
ROIC
2.7%50.2
ROE
1.1%46.7
GP/Assets
33.2%70.3
Op. Margin
1.4%47.4
FCF/Assets
-6.7%33.0
Piotroski
83.5
Int. Cover
19.7x74.5
D/E Ratio
0.28x44.8
Current Ratio
3.01x53.0
Value
31
P/E (TTM)
237.1x3.7
EV/EBITDA
25.8x13.8
P/FCF
N/A
P/B
1.5x66.5
P/S
2.2x65.5
Div Yield
1.5%40.6
Momentum
30
52W High %
42%14.3
RS 6M
-41%28.6
SMA 50/200
0.78x11.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
99.3
Q Growth
-76%4.2

FUNDAMENTALS

Market Cap
$431M
P/E (Forward)
10.8x
Gross Margin
71.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688687.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688687.SSBeijing Kawin Technology Share-Holding Co., Ltd.(you)$431M24SELL
603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd.$452M27SELL
6660.HKAIM Vaccine Co., Ltd.$368M20SELL
688075.SSAssure Tech (Hangzhou) Co., Ltd.$643M27SELL
2197.HKClover Biopharmaceuticals, Ltd.$323M19STRONG SELL
6996.HKAntengene Corporation Limited$347M15STRONG SELL
1167.HKJacobio Pharmaceuticals Group Co., Ltd.$490M12STRONG SELL
688302.SSHinova Pharmaceuticals Inc.$582M14STRONG SELL
6955.HKShandong Boan Biotechnology Co., Ltd.$455M9STRONG SELL
688197.SSShouyao Holdings (Beijing) Co., LTD.$804M19STRONG SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) — Stock Score Summary

Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) has a MoatMap StockRank of 24/100 based on Quality (54/100), Value (31/100), and Momentum (30/100) factor scores. The current signal is SELL. Beijing Kawin is a small biotech firm that lacks internal manufacturing scale, leaving it highly vulnerable to rising manufacturing costs from dominant CDMOs.

Beijing Kawin Technology Share-Holding Co., Ltd. is a biopharmaceutical company specializing in the prevention and treatment of viral infections, with a focus on chronic hepatitis B and C. The company's competitive moat is anchored by its proprietary recombinant human interferon products and a robust pipeline of innovative biologics. It holds a leading position in China's antiviral therapeutic market.

Key Financial Metrics

Price$2.45
Market Cap$431M
P/E (TTM)237.14
P/E (Forward)10.85
Price/Book1.48
Return on Equity1.1%
Return on Invested Capital2.7%
Debt/Equity27.65
Gross Margin71.3%
Operating Margin1.4%
Revenue Growth-10.7%
Dividend Yield1.5%
Free Cash Flow$-4M

Beijing Kawin Technology Share-Holding Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Kawin Technology Share-Holding Co., Ltd.’s (688687.SS) StockRank?
MoatMap’s StockRank for Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) is 24/100, with a Sell signal. It is a composite of Quality (54), Value (31), and Momentum (30) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Kawin Technology Share-Holding Co., Ltd. have an economic moat?
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Kawin Technology Share-Holding Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Kawin Technology Share-Holding Co., Ltd. in?
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).